February 27, 2017 10:00 am
Dogs are great companions, and they also are proving to be great research subjects for cancer. Here's how our canine friends are pointing to possible treatments in human cancer.
February 24, 2017 10:42 am
This article outlines methods to push the throughput of pH gradient IEX even further. To achieve this, a small-particle-size column was operated on an ultra-performance liquid chromatography (UPLC) system.
February 23, 2017 10:15 am
A panel of industry executives came together Feb. 13 at the BIO CEO and Investor Conference in New York City, to discuss challenges in treating pain, and new alternatives in development that don’t have addictive side effects of traditional painkillers.
February 22, 2017 10:17 am
French biopharmaceutical company PharNext SA is taking a different approach to drug development, by identifying new indications for novel combinations of off-patent drugs at low doses.
February 21, 2017 10:19 am
Investigative sites are the heart and soul of clinical trials, essential to ensuring the efficacy and safety of pharmaceutical compounds in humans. Here are ten tips to help optimize site selection.
February 17, 2017 11:25 am
An expert panel convened in New York City on Tuesday at the BIO CEO and Investor Conference to discuss public health policy under the new Administration and what it might mean for the biotech industry.
January 31, 2017 10:34 am
New regulations for research with human blood and tissue try to balance scientific progress with patient privacy.
January 25, 2017 10:46 am
Tony Hoang did not grow up with much. As a boy he began tinkering with broken electronics his parents would buy at thrift stores, developing a knack for fixing the run-down equipment and thus stoking his passion for engineering. Two bachelor’s degrees later and Hoang is now a Ph.D. chemistry candidate who broke the university’s student patent record and officially launched his biotech startup earlier this month.
January 24, 2017 11:04 am
G protein-coupled receptors (GPCRs) are the most commonly exploited target in modern medicine; however, they have historically not been targeted in oncology. Recently, researchers have identified opportunities for targeting GPCRs in oncology, resulting in increased focus by drug developers in using GPCRs as targets in oncology.
January 23, 2017 9:56 am
New research works out how to translate between the language of biology – molecules – and the language of microelectronics – electrons. It could open the door to new kinds of biosensors and therapeutics.
- 1 of 2
- next ›